UNC13A and amyotrophic lateral sclerosis: The incorporation of genetic data in these trials displays the importance of identifying UNC13A in ALS patients, so that more targeted trials may take place in the future, thereby providing lithium carbonate specifically to carriers and further subdividing the genotype.